---
title: 'Industry Daily Summary: What Happened on October 4, 2026'
headline: Brenntag gets global rights to dsm-firmenich’s biopharma vitamins
description: The companies will market eight GMP-grade vitamins for biopharmaceutical
  manufacturing under a new co-brand.
url: https://thebench.bio/news/industry/2026-10-04
topic: industry
date: '2026-10-04'
covers:
- '2026-10-04'
date_published: '2026-10-05T00:01:13Z'
date_modified: '2026-10-05T00:01:13Z'
sources: 1
publisher: The Bench (thebench.bio)
---

# Industry Daily Summary: What Happened on October 4, 2026

**Brenntag gets global rights to dsm-firmenich’s biopharma vitamins**

The companies will market eight GMP-grade vitamins for biopharmaceutical manufacturing under a new co-brand.

## Today in brief

Brenntag Pharma won exclusive global distribution rights to dsm-firmenich’s Biond vitamin portfolio for biopharmaceutical manufacturing. [1] The eight products will be sold as BYPHARM powered by Biond, extending a business relationship of more than 30 years. [1]

## Sources

1. [Brenntag and dsm-firmenich expand biopharma vitamin partnership](<https://pharmafile.com/news/brenntag-and-dsm-firmenich-expand-biopharma-vitamin-partnership/>), Pharmafile, 2026-10-04

---

The Bench wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://pharmafile.com/news/brenntag-and-dsm-firmenich-expand-biopharma-vitamin-partnership/>